UK start-up aims to advance pioneering NK cell therapy
NK:IO raises £1.2M, bringing total Seed funding to £5.1M
02-Aug-2023 -
NK:IO, a start-up company in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2M. This brings total equity financing to £3.2M and will enable the company to reach key milestones in progressing ...
cancer
cell biology
cell therapies
+3